The company has substantially boosted its development of a novel solution for ATTR-CM, leveraging the investigational drug. Early patient information reveals significant outcomes for individuals affected with this https://biotech872813.theisblog.com/42564096/company-progresses-amyloidosis-therapy-through-the-drug